Volume 2, Issue 1 (2-2013)                   ABS 2013, 2(1): 0-0 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Safamanesh S, Pazouki A, Tamannaie Z, Mohammadalipour B, Ramezani K, Hajnasrollah E, et al . Evaluation of Gastrografin Therapeutic Role in the Management of Small Bowel Obstruction. ABS 2013; 2 (1)
URL: http://annbsurg.iums.ac.ir/article-1-261-en.html
1- 1 Minimally Invasive Surgery Research Center, Tehran University of Medical Sciences, Tehran, IR Iran
2- Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
3- Department of Surgery, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
4- 1 Minimally Invasive Surgery Research Center, Tehran University of Medical Sciences, Tehran, IR Iran 4 Faculty of Medicine, Islamic Azad University, Tehran Medical Branch, Tehran, IR Iran
Abstract:   (761 Views)
Background: Small bowel obstruction is one of the most common surgical emergencies and main causes of hospital admissions. Diatrizoate Meglumine Gastrografin, a hyperosmolar water-soluble contrast agent, has been used to triage patients with small bowel obstruction for an operative or a non-operative management. It can also have a therapeutic effect by increasing the pressure gradient across obstructive sites that may result in resolving the obstruction. Objectives: The aim of this study was to test the gastrografin effect in the resolution of small bowel obstruction. Patients and Methods: In this cross sectional–descriptive study, gastrografin was given to patients diagnosed with small bowel obstruction in clinical and radiological grounds . The contrast passage was assessed by serial X-rays. If the contrast remained in the small bowel, a decision was made as to whether proceed to surgical intervention, based on clinical condition. The patients were divided into two groups: A, who finally required surgery, and B, who were resolved by gastrografin administration. Results: Forty six patients were entered into the study. Thirty seven of the patients (80%) received a non-operative course in whom the contrast was observed in the large bowel. They had a mean hospital stay of 4.6 days. Nine patients (20%) required operative intervention. These patients had a mean hospital stay of 8 days. Conclusions: This study has demonstrated that gastrografin was highly effective in the management of adhesive small bowel obstruction resulting in a decreased need for surgery and hospital stay.
Full-Text [PDF 208 kb]   (858 Downloads)    
Type of Study: Original | Subject: MIS
Received: 2020/12/29 | Accepted: 2013/02/15 | ePublished: 2013/02/15

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Annals of Bariatric Surgery

Designed & Developed by : Yektaweb